Thus (megakaryocytic) CCN2 expression appears not to be a key feature in the development of fibrosis in MPN, in contrast to the prominent role that CCN2 plays in the development of fibrosis in many organ diseases outside the marrow [2]. Here, CCN2 is linked to myeloproliferative disorder.